Clinical Trial

Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)

Recruiting
View on ClinicalTrials.gov →
Summary
Taking patients with locally advanced gastric adenocarcinoma (cT2-4a, N-/+, M0) as the research subjects, to evaluate whether the clinical efficacy of laparoscopic beyond D2 regional lymph node dissection for gastric cancer with indocyanine green tracer is better or not.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-20.
Trial Details
NCT Number NCT06945718
Lead Sponsor Fujian Medical University
Conditions Gastric Cancer, Surgery
Enrollment 760 participants
Start Date 2025-05-01
Primary Completion 2027-04-01 (estimated)
Study Completion 2030-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-08